Wellington Management Group LLP cut its holdings in shares of Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 35.4% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,513,588 shares of the company's stock after selling 1,922,875 shares during the period. Wellington Management Group LLP owned 2.93% of Privia Health Group worth $63,982,000 at the end of the most recent reporting period.
A number of other institutional investors have also modified their holdings of PRVA. Millennium Management LLC lifted its position in Privia Health Group by 2,994.2% during the 2nd quarter. Millennium Management LLC now owns 1,138,526 shares of the company's stock worth $19,788,000 after acquiring an additional 1,101,730 shares during the period. Eventide Asset Management LLC grew its position in Privia Health Group by 979.2% in the 3rd quarter. Eventide Asset Management LLC now owns 822,438 shares of the company's stock valued at $14,977,000 after buying an additional 746,231 shares during the last quarter. Icon Wealth Advisors LLC increased its stake in Privia Health Group by 1,910.1% in the 3rd quarter. Icon Wealth Advisors LLC now owns 300,889 shares of the company's stock valued at $5,479,000 after buying an additional 285,920 shares during the period. FMR LLC raised its position in Privia Health Group by 1.5% during the 3rd quarter. FMR LLC now owns 18,169,043 shares of the company's stock worth $330,858,000 after buying an additional 271,645 shares during the last quarter. Finally, BlackBarn Capital Partners LP lifted its stake in shares of Privia Health Group by 100.0% in the 2nd quarter. BlackBarn Capital Partners LP now owns 400,000 shares of the company's stock worth $6,952,000 after acquiring an additional 200,000 shares during the period. 94.48% of the stock is owned by institutional investors and hedge funds.
Analyst Ratings Changes
Several research firms recently issued reports on PRVA. Barclays increased their price target on shares of Privia Health Group from $19.00 to $21.00 and gave the stock an "equal weight" rating in a report on Friday, November 8th. JPMorgan Chase & Co. raised their price target on Privia Health Group from $27.00 to $28.00 and gave the company an "overweight" rating in a report on Friday, November 29th. Truist Financial increased their price objective on Privia Health Group from $24.00 to $27.00 and gave the stock a "buy" rating in a research report on Friday, November 8th. Royal Bank of Canada restated an "outperform" rating and set a $28.00 target price on shares of Privia Health Group in a research report on Wednesday, August 14th. Finally, KeyCorp assumed coverage on shares of Privia Health Group in a report on Friday, October 11th. They issued an "overweight" rating and a $23.00 price target for the company. Two equities research analysts have rated the stock with a hold rating, eleven have issued a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, Privia Health Group presently has a consensus rating of "Buy" and a consensus price target of $24.79.
Check Out Our Latest Stock Report on PRVA
Privia Health Group Stock Down 2.3 %
Shares of PRVA traded down $0.49 during trading on Wednesday, reaching $21.13. The company's stock had a trading volume of 671,659 shares, compared to its average volume of 842,250. Privia Health Group, Inc. has a twelve month low of $15.92 and a twelve month high of $24.30. The company has a market cap of $2.54 billion, a price-to-earnings ratio of 216.20, a P/E/G ratio of 5.51 and a beta of 0.82. The company has a fifty day moving average of $19.75 and a two-hundred day moving average of $18.96.
Privia Health Group Profile
(
Free Report)
Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.
Read More
Before you consider Privia Health Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Privia Health Group wasn't on the list.
While Privia Health Group currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.